Previous Article | Next Article 
Infection and Immunity, July 2004, p. 4224-4232, Vol. 72, No. 7
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.7.4224-4232.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
The galU Gene of Pseudomonas aeruginosa Is Required for Corneal Infection and Efficient Systemic Spread following Pneumonia but Not for Infection Confined to the Lung
Gregory P. Priebe,1,2* Charles R. Dean,3,
Tanweer Zaidi,1 Gloria J. Meluleni,1 Fadie T. Coleman,1 Yamara S. Coutinho,1 Michael J. Noto,3 Teresa A. Urban,3 Gerald B. Pier,1 and Joanna B. Goldberg3
Channing Laboratory, Department of Medicine, Brigham and Women's Hospital,1
Departments of Anesthesia (Critical Care) and Medicine (Infectious Diseases), Children's Hospital, Boston, Massachusetts,2
Health Sciences Center, University of Virginia, Charlottesville, Virginia3
Received 20 December 2003/
Returned for modification 18 February 2004/
Accepted 10 March 2004
Acute pneumonias and corneal infections due to Pseudomonas aeruginosa are typically caused by lipopolysaccharide (LPS)-smooth strains. In cystic fibrosis patients, however, LPS-rough strains of P. aeruginosa, which lack O antigen, can survive in the lung and cause chronic infection. It is not clear whether an LPS-rough phenotype affects cytotoxicity related to the type III secretion system (TTSS). We previously reported that interruption of the galU gene in P. aeruginosa results in production of a rough LPS and truncated LPS core. Here we evaluated the role of the galU gene in the pathogenesis of murine lung and eye infections and in cytotoxicity due to the TTSS effector ExoU. We studied galU mutants of strain PAO1, of its cytotoxic variant expressing ExoU from a plasmid, and of the inherently cytotoxic strain PA103. The galU mutants were more serum sensitive than the parental strains but remained cytotoxic in vitro. In a corneal infection model, the galU mutants were significantly attenuated. In an acute pneumonia model, the 50% lethal doses of the galU mutants were higher than those of the corresponding wild-type strains, yet these mutants could cause mortality and severe pneumonia, as judged by histology, even with minimal systemic spread. These findings suggest that the galU gene is required for corneal infection and for efficient systemic spread following lung infection but is not required for infection confined to the lung. Host defenses in the lung appear to be insufficient to control infection with LPS-rough P. aeruginosa when local bacterial levels are high.
* Corresponding author. Mailing address: Channing Laboratory, 181 Longwood Ave., Boston, MA 02115. Phone: (617) 525-2663. Fax: (617) 525-2510. E-mail:
gpriebe{at}rics.bwh.harvard.edu.
Editor: J. N. Weiser
Present address: Novartis Institutes for Biomedical Research, Cambridge, Mass.
Infection and Immunity, July 2004, p. 4224-4232, Vol. 72, No. 7
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.7.4224-4232.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
King, J. D., Kocincova, D., Westman, E. L., Lam, J. S.
(2009). Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa. Innate Immunity
15: 261-312
[Abstract]
-
Choy, M. H., Stapleton, F., Willcox, M. D. P., Zhu, H.
(2008). Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis. J Med Microbiol
57: 1539-1546
[Abstract]
[Full Text]
-
Priebe, G. P., Walsh, R. L., Cederroth, T. A., Kamei, A., Coutinho-Sledge, Y. S., Goldberg, J. B., Pier, G. B.
(2008). IL-17 Is a Critical Component of Vaccine-Induced Protection against Lung Infection by Lipopolysaccharide-Heterologous Strains of Pseudomonas aeruginosa. J. Immunol.
181: 4965-4975
[Abstract]
[Full Text]
-
Kintz, E., Scarff, J. M., DiGiandomenico, A., Goldberg, J. B.
(2008). Lipopolysaccharide O-Antigen Chain Length Regulation in Pseudomonas aeruginosa Serogroup O11 Strain PA103. J. Bacteriol.
190: 2709-2716
[Abstract]
[Full Text]
-
Vilches, S., Canals, R., Wilhelms, M., Salo, M. T., Knirel, Y. A., Vinogradov, E., Merino, S., Tomas, J. M.
(2007). Mesophilic Aeromonas UDP-glucose pyrophosphorylase (GalU) mutants show two types of lipopolysaccharide structures and reduced virulence. Microbiology
153: 2393-2404
[Abstract]
[Full Text]
-
Srivastava, A., Casey, H., Johnson, N., Levy, O., Malley, R.
(2007). Recombinant Bactericidal/Permeability-Increasing Protein rBPI21 Protects against Pneumococcal Disease. Infect. Immun.
75: 342-349
[Abstract]
[Full Text]
-
Furukawa, S., Kuchma, S. L., O'Toole, G. A.
(2006). Keeping Their Options Open: Acute versus Persistent Infections. J. Bacteriol.
188: 1211-1217
[Full Text]
-
Zaidi, T. S., Priebe, G. P., Pier, G. B.
(2006). A Live-Attenuated Pseudomonas aeruginosa Vaccine Elicits Outer Membrane Protein-Specific Active and Passive Protection against Corneal Infection. Infect. Immun.
74: 975-983
[Abstract]
[Full Text]
-
Winstanley, C., Kaye, S. B, Neal, T. J, Chilton, H. J, Miksch, S., Hart, C A., and the Microbiology Ophthalmic Group,
(2005). Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J Med Microbiol
54: 519-526
[Abstract]
[Full Text]
-
Koh, A. Y., Priebe, G. P., Pier, G. B.
(2005). Virulence of Pseudomonas aeruginosa in a Murine Model of Gastrointestinal Colonization and Dissemination in Neutropenia. Infect. Immun.
73: 2262-2272
[Abstract]
[Full Text]